Comorbid Insomnia and Sleep Disordered Breathing in Patients Undergoing Cardiac Rehabilitation

CompletedOBSERVATIONAL
Enrollment

43

Participants

Timeline

Start Date

August 19, 2021

Primary Completion Date

May 2, 2024

Study Completion Date

May 2, 2024

Conditions
Coronary Artery DiseaseSleep Disorder; Breathing-RelatedSleep Disorder; Insomnia Type
Interventions
DIAGNOSTIC_TEST

Polysomnograpy

Home polysomnography will be conducted using the scalable, modular Embletta system. Trained staff will instrument the participants in the evening and perform biocalibration to ensure optimal data quality

DIAGNOSTIC_TEST

actigraphy

A water resistant accelerometer with light sensor and event marker will be worn on the nondominant wrist for approximately 7 days. Activity counts from the device will be analyzed by proprietary software algorithms for determination of the following: sleep onset, sleep offset, total sleep time, total wake time, and sleep efficiency.16 Daytime sleep periods will be also scored to determine frequency and duration of naps. Daily data will be averaged across the 7-day period, as well as separately for weekdays and weekend, to compute measures of habitual sleep patterns.

Trial Locations (1)

55905

Mayo Clinic Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Sleep Number, Inc.

UNKNOWN

lead

Mayo Clinic

OTHER

NCT04992676 - Comorbid Insomnia and Sleep Disordered Breathing in Patients Undergoing Cardiac Rehabilitation | Biotech Hunter | Biotech Hunter